Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study

In the prospective RUN-UC study with PS-weighted groups, UST showed higher treatment persistence but no significant difference in maintenance effectiveness compared to anti-TNF or VDZ in UC.

Authors

Institutions

Publication Details

Journal
Journal of Crohn s and Colitis
Published
2025-03-27
DOI
https://doi.org/10.1093/ecco-jcc/jjaf052
Citations
2
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
3.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study

Wolfgang Mohl, Matthias Kahl, Leo Trentmann, Sandra Plachta‐Danielzik et al.
2 citations
Journal of Crohn s and Colitis
Inflammatory Bowel Disease
3.63
article

Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study

Wolfgang Mohl, Matthias Kahl, Leo Trentmann, Sandra Plachta‐Danielzik, Robert Ehehalt, Philipp Efken, Thomas Krause, Andreas Lügering, Stefanie Howaldt, Bernd Bokemeyer, Stefan Schreiber, Christoph Jochum, Petra Hartmann, Elisabeth Schnoy, Elena Gilman
article en
2 citations

Abstract

In the prospective RUN-UC study with PS-weighted groups, UST showed higher treatment persistence but no significant difference in maintenance effectiveness compared to anti-TNF or VDZ in UC.

Journal of Crohn s and ColitisVol. 19(5)
University of Kassel (DE), Kielce University of Technology (PL), University Hospital Augsburg (DE), University Hospital Heidelberg (DE), Hochschule für Angewandte Wissenschaften Kiel (DE), Christian-Albrechts-Universität zu Kiel (DE), University Hospital Münster (DE), University Hospital Schleswig-Holstein (DE), IS practice (BE), Hamburg Institut (Germany) (DE), Crohn's and Colitis UK (GB), Klinikum Kassel (DE), Klinikum Bremen-Mitte (DE), Klinikum Saarbrücken (DE), Hamburg Institute for Therapy Research (DE), Johannes Wesling Klinikum Minden (DE), Clinical Research Center Kiel (DE), Charité - Universitätsmedizin Berlin (DE), University of Lübeck (DE)
Good health and well-being
Openalex Percentile: Top 9%
Inflammatory Bowel Disease
3.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.